Indoco Remedies is currently trading at Rs. 357.00, up by 11.15 points or 3.22% from its previous closing of Rs. 345.85 on the BSE.

The scrip opened at Rs. 350.45 and has touched a high and low of Rs. 363.00 and Rs. 350.10 respectively. So far 81 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 416.95 on 01-Jan-2024 and a 52 week low of Rs. 307.00 on 26-Apr-2023.

Last one week high and low of the scrip stood at Rs. 377.00 and Rs. 342.95 respectively. The current market cap of the company is Rs. 3289.77 crore.

The promoters holding in the company stood at 58.74%, while Institutions and Non-Institutions held 21.25% and 20.00% respectively.

Indoco Remedies’ wholly owned subsidiary -- Warren Remedies has commenced its commercial production from its Greenfield manufacturing facility located at Aurangabad, Maharashtra to manufacture Oral Care Products. Warren Remedies has commenced its commercial production on March 1, 2024. The said manufacturing facility will provide the company requisite capabilities and edge in meeting demand of Oral Care Products.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.